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Abstract
Background: To be transmitted by its mosquito vector, dengue virus (DENV) must infect midgut
epithelial cells, replicate and disseminate into the hemocoel, and finally infect the salivary glands,
which is essential for transmission. The extrinsic incubation period (EIP) is very relevant
epidemiologically and is the time required from the ingestion of virus until it can be transmitted to
the next vertebrate host. The EIP is conditioned by the kinetics and tropisms of virus replication
in its vector. Here we document the virogenesis of DENV-2 in newly-colonized Aedes aegypti
mosquitoes from Chetumal, Mexico in order to understand better the effect of vector-virus
interactions on dengue transmission.
Results: After ingestion of DENV-2, midgut infections in Chetumal mosquitoes were
characterized by a peak in virus titers between 7 and 10 days post-infection (dpi). The amount of
viral antigen and viral titers in the midgut then declined, but viral RNA levels remained stable. The
presence of DENV-2 antigen in the trachea was positively correlated with virus dissemination from
the midgut. DENV-2 antigen was found in salivary gland tissue in more than a third of mosquitoes
at 4 dpi. Unlike in the midgut, the amount of viral antigen (as well as the percent of infected salivary
glands) increased with time. DENV-2 antigen also accumulated and increased in neural tissue
throughout the EIP. DENV-2 antigen was detected in multiple tissues of the vector, but unlike some
other arboviruses, was not detected in muscle.
Conclusion: Our results suggest that the EIP of DENV-2 in its vector may be shorter that the
previously reported and that the tracheal system may facilitate DENV-2 dissemination from the
midgut. Mosquito organs (e.g. midgut, neural tissue, and salivary glands) differed in their response
to DENV-2 infection.
Background
Dengue is an arthropod-borne viral disease of major pub-
lic health importance worldwide. Currently, the dengue
pandemic affects more than 100 countries, including
nations in Africa, the Americas, the Indian subcontinent,
Southeast Asia, the Eastern Mediterranean, and the West-
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estimates there are 50 million annual cases of dengue
infection worldwide, about 500,000 hospital admissions,
and 22,000 dengue-related deaths. Globally, more than
2.5 billion people are at risk for this disease. The emer-
gence of dengue in the Americas has been especially dra-
matic [2,3].
Dengue virus (DENV) is comprised of four closely related,
but antigenically distinct serotypes (DENV-1, DENV-2,
DENV-3 and DENV-4), multiple genotypes enclosed in
each serotype [4]. The Aedes aegypti mosquito is the pri-
mary vector for all four serotypes. The mosquitoes
become infected after feeding on a viremic individual,
then a reported EIP of 7–14 days is required before the
mosquitoes can transmit the virus to a new host [2,5].
Environmental factors (including temperature and
humidity) as well as intrinsic factors (such as vector com-
petence and viral genotype) affect the EIP [6].
Host organ and cell susceptibility and permissiveness con-
dition virus tropisms in an organism [7]. A number of
studies have investigated DENV-vector interactions [8-
14], and the important role of virus genotype in efficient
Aedes aegypti infection has been revealed [15]. In this
study, we wanted to determine the virogenesis of DENV-2
infection in recently colonized vector mosquitoes from a
dengue endemic area, which previously had been shown
to be very susceptible to DENV infection [16].
In the natural course of infection for the virus, DENV is
ingested in a blood meal, then it encounters and must
overcome midgut infection and escape barriers [17],
which vary among mosquito populations. Infection of
mosquito midguts is known to occur in a dose-dependent
manner [16]. Elucidation of the kinetics of replication and
tropism of virus in recently colonized (field relevant)
Aedes aegypti mosquitoes would provide a better under-
standing of transmission potential and vector-virus inter-
actions that condition dengue epidemiology and
epidemic potential. In this study, we determined: 1) the
kinetics of DENV infection in orally infected mosquitoes,
2) the DENV-2 tropisms for different mosquito tissues
and organs, 3) a possible anatomic explanation for virus
dissemination from the midgut, and 4) the minimal time
required for infection of salivary glands in recently colo-
nized Aedes aegypti mosquitoes from Chetumal, Mexico
and in a long colonized or a selected Aedes aegypti strain.
Results
Aedes aegypti mosquito susceptibility to DENV-2 
Jam1409
The three Aedes aegypti mosquito strains tested were sus-
ceptible to DENV-2 Jam1409 midgut infection and dis-
semination, as determined by detection of DENV-2
antigen in midguts and head tissues at day 14 post blood
infection (dpi) (Figure 1). The midgut infection rates
(MIR) were similar between Chetumal (87 ± 8%) and
D2S3 (90 ± 7%), while they were lower in Rex-D (70 ±
7%) mosquitoes. The dissemination rates (DR) in Chetu-
mal mosquitoes were greater (78 ± 10%) than in the lab-
oratory-adapted Rex-D mosquitoes (57 ± 10%). As
expected, the greatest dissemination rates were observed
in the D2S3 mosquitoes (90 ± 7%). An ANOVA-one way
analysis indicated that means were significantly different
for MIR (P = 0.006) as well as for DR (P = 0.002) among
the three mosquito populations. The MIR and DR
between Chetumal and D2S3 mosquitoes did not differ
significantly.
DENV-2 Jam1409 initial infection, replication, and 
modulation of infection in midguts
After ingestion of DENV-2, midguts were the first tissues
to become infected. At 2 dpi, a few individual infected epi-
thelial cells were distinguishable in ~30% of midguts. By
day 3, midgut infection foci involved multiple cells. Infec-
tion spread laterally from this initial stage to the neighbor-
ing cells (probably due to virus release by budding as
observed in invertebrate cells), frequently involving the
entire organ by 7–10 dpi. Then, starting at day 10, but
more noticeably at 14 dpi, the amount of viral antigen in
the midgut began to decline. At 21 dpi viral antigen was
almost undetectable, by either the polyclonal or mono-
clonal anti-dengue antibodies, in midguts of Chetumal
DENV-2 midgut infection (MIR) and dissemination rates (DR) in Aedes aegypti mosquitoesFigur  1
DENV-2 midgut infection (MIR) and dissemination 
rates (DR) in Aedes aegypti mosquitoes. MIRs and DRs 
for Chetumal, Rex-D, and D2S3 mosquito strains at 14 dpi as 
described in Materials and Methods. The mean and standard 
deviation values were obtained from four independent 
experiments (n= 50–60 mosquitoes).Page 2 of 13
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shown). In contrast, other organs and tissues, including
fat body, salivary glands, and nervous system in the same
Chetumal mosquitoes contained large amounts of virus
antigen during the time course.
DENV-2 + sense RNA as well as infectious virus in Chetu-
mal mosquito midguts was quantified by Q-PCR and end
point titration, respectively, at 7, 14 and 21 dpi. In this
time frame, the viral RNA remained stable (between 7.2 to
7.6 Log10 RNA copy/midgut) as determined by Q-PCR
(Figure 3-A). In contrast, between 7 and 21 dpi, virus titers
decreased from 6 to 4 Log10 TCID50/midgut (P < 0.001)
as determined by end point titrations (Figure 3-B).
Presence of viral antigen in the tracheal system correlates 
with DENV-2 dissemination in Chetumal mosquitoes
Analysis of mosquitoes between 2 and 10 dpi revealed the
presence of DENV-2 antigen in portions of the tracheal
system in 35 ± 5% of blood fed mosquitoes. The earliest
detection of DENV-2 antigen in the tracheal system
occurred at 2 dpi, continued at 3, 4, 5, and 7 dpi and then
decreased notably. Viral antigen was not detected through
out the tracheal system; rather it was confined to small
sections of trachea mostly from the abdominal area and it
displayed a characteristic distribution pattern (Figure 4).
The presence of viral antigen in trachea and virus dissem-
ination out of the midgut in Chetumal mosquitoes were
strongly correlated at 2, 3 and 5 dpi (Table 1). This associ-
ation was gone by 7 dpi (Table 1) and thereafter (data not
shown). The criterion for disseminated infection was the
presence of viral antigen in any organ or tissue other than
the midgut or the tracheal system: early dissemination
was detected most frequently in abdominal and throracic
fat body, salivary glands and nerve cells and tissues. In
contrast to the Chetumal mosquitoes, viral antigen was
rarely associated with trachea of infected Rex-D mosqui-
toes.
DENV-2 disseminates rapidly to salivary glands in 
Chetumal mosquitoes
DENV-2 was detected in the salivary glands of 36% of
blood fed Chetumal mosquitoes at 4 dpi. In the Rex-D
mosquitoes, this salivary gland infection rate did not
occur until 10 dpi and at 7 dpi only < 15% of salivary
glands of Rex-D mosquitoes contained viral antigen. Early
on the infection, the distal region of the lateral lobes was
frequently the area of the salivary gland to contain viral
antigen; medial and proximal lobes became infected later.
The cells in the distal lateral lobe may contain DENV
receptors or more receptors, but this remains to be deter-
mined. The percentage of infected salivary glands as well
as the amount of viral antigen in the gland increased over-
time, revealing a major DENV-2 tropism for this tissue
(Figure 5).
DENV-2 tropisms for various tissues and organs in 
mosquito
The tropisms of DENV-2 Jam1409 to organ-tissues other
than midguts and salivary glands were determined over
time in Chetumal mosquitoes. DENV-2 antigen was
detected in head tissues at 5 dpi, and antigen continued to
accumulate in these tissues throughout the EIP. Viral anti-
gen was detected in fat body of the abdominal, thoracic or
cephalic regions consistently throughout the time course.
DENV-2 dissemination to abdominal fat body was
detected in 35 % of mosquitoes between 2 and 3 dpi (Fig-
ure 6, panel A) and in 62% of abdominal tissues at the
other time points. Thus, fat body represents a major site
for DENV-2 replication in the vector. Interestingly the fat
body also plays a key role in triggering the insect immune
response against pathogens. Hence, it would be important
to determine potential effects of virus infection of the fat
body on vector competence.
The musculature surrounding the midgut did not contain
virus antigen at any of the examined time points in any of
the mosquito populations included in our study (Figure
6-C). Other organs and infected tissues included: trachea,
esophagus (Figure 6-E), hemocytes (Figure 6-F), omma-
tidia of the compound eye (Figure 6-G), nerve tissue (Fig-
ure 6-H), and malphigian tubules (Figure 6-I).
Occasionally DENV-2 antigen was observed in anterior
midgut (Figure 6-D) and not in the hindgut (Figure 6-I) or
cardia (Figure 6-E). Taken together, these data revealed
the general kinetics of infection and tropisms of DENV-2
in mosquito as shown in Figure 7.
Kinetics of DENV-2 viral titers in Chetumal mosquitoes
To establish the overall kinetics of DENV-2 replication,
viral titers were determined by plaque assay of individual
mosquitoes at different time points (Figure 8). DENV-2
titers increased over time and ranged from 2.2 to 5.5
Log10 PFU/mosquito. Infectious virus was first detectable
at 3 dpi. Two slight drops in the overall viral titers were
observed: one at 14 dpi and the other at 21 dpi. Kinetics
of virus replication during the DENV-2 infection at vari-
ous time points are shown in Figure 8.
Discussion
Each of the mosquito strains examined were susceptible
to DENV-2. However, the Chetumal and D2S3 strains
were clearly more susceptible to DENV-2 infection than
the Rex-D mosquitoes (Figure 1). DENV-2 replication in
infected Rex-D mosquitoes was also slower than in Chetu-
mal mosquitoes (data not shown). Unfortunately, we did
not have a long colonized strain of Chetumal mosquitoes
to compare to the newly colonized strain. Colonization
has been shown to select for certain genotypes in Aedes
aegypti [18]. Thus the use of long-colonized mosquitoes as
well as high passaged viruses from an area could con-Page 3 of 13
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Kinetics of DENV-2 midgut infection after oral challenge of Aedes aegyptiF gure 2
Kinetics of DENV-2 midgut infection after oral challenge of Aedes aegypti. Chetumal mosquito midguts dissected at 
different time points (n = 30 for each time point) were assayed by IFA to detect DENV-2 viral antigen (green). At each time 
point two representative midguts from Chetumal mosquitoes are presented. Controls are an uninfected midgut and a dengue 
infected midgut (in red midgut musculature). The magnification was 100×.
BMC Microbiology 2007, 7:9 http://www.biomedcentral.com/1471-2180/7/9found the interpretation of the actual epidemic potential
of DENV in that area. It would be prudent to study vector-
pathogen interactions using field-relevant mosquitoes as
well as low passage viruses from a specific area in order to
draw more precise conclusions about the risk of dengue
transmission in that area.
It was surprising that the Chetumal mosquitoes were as
permissive to DENV-2 productive infection as the D2S3
strain, which was selected for DENV susceptibility [19].
The susceptible phenotype is likely conditioned by differ-
ent genetic mechanisms, which remain to be determined.
However, the results do confirm previous studies demon-
strating that mosquitoes from the eastern portion of the
Yucatan Peninsula (an endemic area for dengue) are
remarkably competent vectors for DENV [16].
DENV-2 infection was detected in midgut epithelial cells
as early as 2 dpi. Viral titers and virus antigen then
increased until 10 dpi when both virus titer and antigen
decreased (Figure 2 and 3). In contrast, Q-PCR revealed
that viral RNA copy number remained fairly constant even
late into the EIP (Figure 3). Conversely, DENV-2 antigen
was not cleared from salivary glands or neural tissues at
equivalent time points. The former observation is of inter-
est, because once a mosquito is productively infected with
an arbovirus, she is capable of transmitting the virus for
life. Obviously, any virus modulation in the salivary
glands would be epidemiologically significant since trans-
mission efficiency could be reduced. Modulation of virus
in the midgut is provocative; either the virus or the epithe-
lium is active in modulating the virus infection. The con-
tinued presence of DENV-2 RNA suggests a probable
mechanism of persistence in vectors. DENV-2 as other
arboviruses can persistently infect insect and human cell
lines and arthropod vectors [20-23]. It is unlikely that the
modulation is conditioned by the metabolic activity of
the midgut epithelium, because a second uninfectious
bloodmeal provided 14 days after DENV-2 infection of
Aedes aegypti failed to reestablish virus production in the
midgut (data not shown). The decline in infectious virus
and viral antigen may be associated with an antiviral
response, post-transcriptional or post-translational
repression, or other self-limiting factors such as epithelial
cells physiological status (i.e. cell aging). Further studies
will be necessary to elucidate the molecular determinants
of this phenomenon.
The mechanism(s) by which DENV disseminates from the
midgut are not well understood. This study suggests that
the mosquito tracheal system may be implicated in DENV
dissemination (Figure 4 and Table 1). The presence of
Quantification of DENV-2 RNA and infectious virus in midguts revealed significant differencesFigure 3
Quantification of DENV-2 RNA and infectious virus in midguts revealed significant differences. Midguts (n = 15) 
from orally infected Chetumal mosquitoes were assayed to quantify viral RNA by Q-PCR and infectious particles by end point 
titrations at different time points. A) Viral RNA decreased slightly between 7 and 14 dpi and then remained stable, * P < 0.05. 
B) Viral titers declined significantly at 14 and 21 dpi, *** P < 0.0001.Page 5 of 13
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with DENV-2 dissemination, mostly between 3 and 5 dpi.
Tracheoles are part of the tracheal system, are 0.2 to 1 µm
in diameter, are fluid-filled, and reach every tissue in the
insect. The tracheal system has been reported to act as dis-
semination conduit for different viruses in insects. Nota-
ble examples are Autographa californica M nuclear
polyhedrosis virus (AcMNPV) infecting Trichoplusia ni,
nucleopolyhedrovirus infecting Bombyx mori, and Sindbis
virus in Aedes albopictus [24,25]. The tracheal system is
also suspected to be the midgut escape conduit for Vene-
zuelan equine encephalitis virus (VEEV) in Ochlerotatus
taeniorhynchus [26]. However, this is the first report indi-
cating that DENV may use the mosquito tracheal system
during dissemination.
Unlike a number of other arboviruses, DENV displayed
no tropism for midgut-associated (Figure 6-C) or flight
muscles. Rift Valley Fever virus infects both skeletal and
visceral muscles [27]. Sindbis virus replicates in visceral
muscles of Aedes albopictus [28]. West Nile virus infects the
contiguous muscles of the posterior and anterior midgut
in Culex mosquitoes [29]. The reasons for mosquito mus-
cle refractoriness to DENV are unknown and require fur-
ther analysis. Rift Valley fever virus and Sindbis alphavirus
exhibit tropisms for cardia tissue [11,30], while DENV-2
was not routinely found in this tissue.
Interestingly, DENV-2 infection was detected in 36% of
Chetumal mosquito salivary glands by 4 dpi. In contrast,
< 15% of Rex-D mosquitoes had infected salivary glands
DENV-2 antigen in the tracheal system of Chetumal mosquitoes following infectionFigure 4
DENV-2 antigen in the tracheal system of Chetumal mosquitoes following infection. DENV-2 antigen was detected 
by IFA in trachea of Chetumal mosquitoes at 2, 3, 4, 5, and 7 dpi (n= 40–50). Midgut- associated tracheal system (A) and unin-
fected trachea using light (B) and fluorescence (C) microscopy. Green arrows point to portions of DENV-2 infected trachea 
(E-L) (200×).Page 6 of 13
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detected until 10 dpi. The Chetumal mosquitoes would
seem to be more vector competent than the Rex-D mos-
quitoes. Reportedly the EIP for DENV is between 7 and 14
days, and it can be affected by conditions such as temper-
ature, humidity and viral dose [2,5,6,31]. Blood meals
provided to mosquitoes in our studies contained 1.7 ± 0.7
× 107 PFU/ml, which is likely biologically relevant, since
viremia titers of DENV-2 in humans may vary from 102 to
107 PFU/ml or 103 to 108 TCID50/ml [32,33]. In our obser-
vations, the lateral distal lobes were frequently the first
site to become infected in the salivary glands, the medial
and proximal lobes developed infection later (Figure 5).
This pattern probably results from the higher virus recep-
tor concentration in this region of the salivary glands, but
this remain to be determined. The lateral distal lobes par-
ticipate prominently in the secretion of enzymes and pro-
teins involved in hematophagy [34,35], therefore
infection of this region might promote early virus trans-
mission. Other studies have demonstrated that DENV-2
can be transmitted by mosquitoes with < 25% salivary
gland tissue infected, if infection occurred in lateral lobes
[31]. Thus, our results suggest that the EIP for DENVs may
be shorter than the commonly reported (at least with
some strains of the vector). There is no sensitive and reli-
able laboratory animal model for dengue, and currently
used in vitro assays for transmission may fail to detect
small but transmissible amounts of virus at earlier times.
However further studies will be necessary to demonstrate
that infectious virus is being transmitted early in the EIP
and that the results can be extrapolated to low passaged
DENV strains.
A shorter EIP for dengue would have important epidemi-
ological consequences in dengue transmission. In nature,
Aedes aegypti female mosquitoes feed frequently and
almost exclusively on humans, which confers greater fit-
ness than feeding on other hosts [36]. These highly
anthropophilic mosquitoes may ingest 2 to 3 bloodmeals
during a single gonadotropic cycle, feeding with a fre-
quency of 0.63 to 0.76 times a day [37]. Aedes aegypti mos-
quitoes, with a very short EIP, persistently infected
salivary glands, and the ability to feed multiple times
within a gonadotropic cycle, would seem to be the ulti-
mate DENV vector, which could help explain the epi-
demic potential of dengue.
Conclusion
The results with the recently colonized Chetumal mosqui-
toes indicate that the EIP for DENVs may be shorter than
the commonly reported, which could have important epi-
demiological consequences in dengue transmission. The
mosquito tracheal system appears implicated in virus dis-
semination from the midgut, and viral infection in the
vector is differentially modulated in different organs.
DENV-2 exhibits differences in certain tissue tropisms in




The newly-colonized Aedes aegypti Chetumal strain was
characterized for its vector competence for DENV-2
[16,38]. Chetumal mosquitoes (F3 – F6) were originally
collected from in the Yucatan Peninsula, Mexico. Mosqui-
toes were hatched and reared as reported previously
[16,17,38]. After hatching female pupae were separated
from males by size, since males are significantly smaller;
transferred in plastic cups to cardboard cartons and
allowed to emerge. Adult mosquitoes were maintained at
28°C, 70–80% relative humidity, with a 12–12 h light-
dark photoperiod. Mosquitoes used as controls in tropism
experiments were the Puerto Rico-Rex-D strain (a long
colonized laboratory strain) [39] and the D2S3 strain (a
laboratory selected, highly susceptible mosquito strain
lacking a midgut escape barrier) [19].
Virus propagation
A high passage DENV-2 strain (Jamaica 1409) [40] was
obtained from the Centers for Diseases Control and Pre-
vention (CDC- Fort Collins, CO, USA). The virus had
been routinely passaged (> 25 times) in C6/36 cell cul-
ture, but there were only two relevant changes in compar-
ison to the low passaged virus as the full-length sequence
analysis indicated [41]. These changes were a conservative
amino acid substitution in E6 protein (Ile→Met) and a
nucleotide change in the 3'UTR143 (G→T). The C6/36 cell
cultures were infected at a multiplicity of infection (MOI)
of 0.001 and incubated at 28°C for a week. At day 7, the
medium was replaced with fresh medium, and at 12 days
post-infection virus was harvested to prepare infectious
bloodmeals [16,42].
Table 1: The presence of DENV-2 antigen in the tracheal system 
correlates with early dissemination in Chetumal mosquitoes
2dpi 3dpi 5dpi 7dpi
DENV-2 infection Trachea Trachea Trachea Trachea
(+) (-) (+) (-) (+) (-) (+) (-)
Disseminated 5 1 10 4 16 2 5 12
Non-Disseminated 1 12 2 8 1 3 2 3
Total 6 13 12 12 17 5 7 15
χ2 10.87 6.17 7.28 0.199
Significance ρ < 0.001 ρ < 0.01 ρ < 0.01 ρ >0.05
The association of detection of viral antigen in the tracheal system 
with early dissemination of the virus was analyzed using 2 × 2 tables 
for each dpi. The criterion for dissemination of infection was 
detection of viral antigen in non-midgut tissues, including head squash 
tissues, fat body, and salivary glands.Page 7 of 13
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DENV-2 tropism for Aedes aegypti salivary glandsFigure 5
DENV-2 tropism for Aedes aegypti salivary glands. Salivary glands were dissected at the time points noted, fixed, and 
assayed for virus antigen by IFA (n = 30–50). Representative salivary glands (200×) from Chetumal and Rex-D mosquitoes at 
each time point are shown. DENV-2 virus antigen increased in the salivary glands through out the EIP. Negative controls (A 
and B) and salivary glands examined with light microscopy (C) are shown. In Rex-D mosquitoes, at 4 dpi viral antigen was typi-
cally associated with the fat body surrounding the salivary glands. In contrast salivary gland tissues of Chetumal mosquitoes 
contained viral antigen at 4 dpi.
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DENV-2 tropisms in different tissues and organs of Aedes aegyptiFigure 6
DENV-2 tropisms in different tissues and organs of Aedes aegypti. DENV-2 viral E antigen distribution in different tis-
sues and organs was revealed by IFA (green for FITC or Alexa 488) in Chetumal mosquitoes (n = 20). A) DENV-2 antigen in fat 
body of mosquito abdomen at 2 dpi. B) DENV-2 infected epithelial cells in midgut (4 dpi). C) DENV-2 is present in epithelial 
cells but absent in midgut-associated muscle (red phalloidin-Alexa® 546). D) DENV-2 in anterior midgut at 5 dpi. E) Infected 
esophagus at 7 dpi, dr.dv. dorsal diverticulum, car: cardia, oe: esophagus, and cr: crop. F) Hemocytes infected with DENV-2 at 
10 dpi. G) Ommatidia of the compound eye exhibiting viral antigen at 12 dpi. H) Nervous system tissue profusely infected by 
DENV-2 at 14 dpi. I) Malphigian tubules expressing viral antigen (Mal. Tu.) at 16 dpi, il: ileum. These pictures represent the 
infection patterns observed. Original magnification was 200×, but pictures were cropped in Adobe Photoshop to improve 
presentation.
BMC Microbiology 2007, 7:9 http://www.biomedcentral.com/1471-2180/7/9Oral infection of mosquitoes with DENV-2
Aedes aegypti mosquitoes were challenged with DENV-2
Jam1409 using an artificial bloodmeal [16]. Briefly, 100–
150 Aedes aegypti female mosquitoes, 4 – 7 days post-
emergence, were deprived of sugar for 24 h and water for
8 h prior to the bloodfeeding. The virus-infected cell mon-
olayers were scraped from the flask surface, and 2 ml of
this suspension was added to an equal amount of washed
sheep erythrocytes to prepare the infectious bloodmeal,
which was provided to the mosquitoes using a membrane
feeding device. The meal was maintained at 37°C by cir-
culating warm water though an external jacket. Mosqui-
toes were not allowed to feed longer than 45 min to
prevent a decline in viral titers. Blood meals contained
viral titers of 1.7 ± 0.7 × 107 PFU/ml. Blood fed mosqui-
toes were separated using a chill table, transferred to clean
cartons, and maintained at as noted above.
Indirect immunofluorescence assays (IFA)
To determine viral tropisms, mosquito (n = 30–40) tis-
sues were examined for the presence of virus antigen after
dissecting midguts and salivary glands and squashing
their thoraxes, heads, and abdomens on slides.
Midguts were dissected in PBS and fixed in 4% parafor-
maldehyde (Electron Microscopy, Hatfield, PA) for at
least 4 h. The fixative was then removed, rinsed once in
PBS, and then incubated for 1 h at room temperature with
constant rocking in a solution containing: 1× PBS-Ash-
burner's solution (13 mM NaCl, 0.7 mM Na2HPO4, 1 mM
NaH2PO4 at pH = 7.2), 1% Bovine Serum Albumin, and
0.1% Triton X-100, called PBT-0.1 (PBS-BSA-Triton). Typ-
ically to detect DENV-2 antigen by IFA, the primary anti-
body was the serotype-specific mouse 3H5–1 monoclonal
antibody (ATCC number HB-46). To confirm the decline
in DENV-2 antigen in midguts, a polyclonal human anti-
dengue specific antibody (Biodesign International, Saco,
ME) was also used as the primary antibody. Midguts were
then incubated with a 1:400 dilution of goat-antimouse
antibody conjugated with Alexa-488 fluorochrome
(Molecular Probes Inc, Eugene, OR). Midguts were
washed twice with PBT-0.1 with constant rocking at room
temperature for 2 hr and incubated with a 1:40 dilution of
Phalloidin-Alexa 546 (Molecular Probes Inc, Eugene, OR)
for 20 min. Midguts were rinsed with PBS and placed onto
slides, covered with Vectashield® (Vector Laboratories Inc,
Burlingame, CA), and a coverslip was sealed with nail
Temporal tropisms of DENV-2 in Chetumal mosquitoesFigure 7
Temporal tropisms of DENV-2 in Chetumal mosquitoes. Infection rates in the respective organ or tissue are shown by 
the gray scale. Percentages were obtained after dissecting, staining and analyzing individual mosquitoes (n = 20–30) at each time 
point. Mosquitoes were assayed at 1, 2, 3, 5, 7, 10, 14, 18 and 21 dpi.Page 10 of 13
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Olympus BH2-RFCA epifluorescence microscope or a
confocal microscope (FVX-IHRT Fluoview Confocal, LSM,
Olympus).
Salivary glands were dissected in PBS onto Vectabond®
(Vector Laboratories Inc, Burlingame, CA) pretreated
slides, fixed in cold acetone or fixed in 4% paraformalde-
hyde- 2% glutaraldehyde, and maintained at 4°C until
immunosassay. Abdomens, thoraxes and heads were
squashed on glass Vectabond®-pretreated slides, fixed in
cold acetone for 15 min, and kept at 4°C
IFA was used to detect DENV-2 antigen in salivary glands,
thoraxes, abdomens and heads. The primary serotype-spe-
cific monoclonal DENV-2 antibody 3H5-1 was diluted
1:200 in PBS and incubated for 1 h on the tissue. Slides
were then washed twice for 5 min with PBS, and goat-anti-
mouse avidin-conjugated secondary antibody containing
0.01% Evans Blue (1:200; Amersham Pharmacia Biotech,
Piscataway, NJ) was added. After 40 min, samples were
washed 2× in PBS and incubated for 20 min with a 1:200
dilution of fluorescein-streptavidin (Amersham Pharma-
cia Biotech, Piscataway, NJ). Following two additional
PBS washes of 5 min each and one with distilled water,
DABCO oil was added to the tissues and coverslips were
added. All the incubations were performed at 37°C. An
Olympus BH2-RFCA fluorescence microscope was used to
examine slides.
Determination of midgut infection and dissemination rates
The midgut infection rate (MIR) was determined as the
number of midguts containing DENV-2 antigen divided
by the number of midguts examined. The dissemination
rate (DR) was determined as the number of mosquitoes
with detectable DENV-2 antigen in non-midgut tissues
(eg, head squash tissues, salivary glands, fat body, etc.),
divided by the number of mosquitoes with detectable
virus antigen in the midgut.
Virus titration
Viral titers in midguts were determined by end point titra-
tions (TCID50) in C6/36 cells. Titers were established
using the microtiter plate titration assay described by Sch-
oepp and Beaty [43], and endpoints were calculated by
the Karber method [44] and expressed as log10 TCID50/ml.
To determine viral titers in whole mosquitoes as well as in
some midguts, plaque assay titrations in LLC-MK2 cells
were used modifying the protocol originally reported by
Malewicz and Jenkin [45].
DENV- 2 quantitative real time RT-PCR (Q-PCR)
DENV-2 genome copy number was determined Q-PCR in
homogenized and filtered tissue from individual mosqui-
toes or midguts [38][46]. RNA for PCR assays was
extracted using QIAamp® Viral RNA Kit (Qiagen Sciences,
Maryland, MA). The reaction mixture was prepared with
1× DyNAzyme® buffer (Finnzymes, Espoo, Finland), 0.2
mM dNTP mix, 0.5× SYBRGreen I (Molecular Probes Inc,
Eugene, OR), 2.5 mM MgCl2, 10 µM of forward and
reverse primers (5'CAAGTCGAACAACCTGGTCCAT3'
and 5'GCCGCACCATTGGTCTTCTC3' respectively), 0.4U
DyNAzyme II Recombinant DNA Polymerase
(Finzymmes, Espoo, Finland), and 2 µl cDNA in a final
volume of 20 µL. The SYBR Green I 10,000× stock was
diluted in DMSO to a working solution of 100×, which
was stored at -20°C in 15 µL aliquots to minimize expo-
sure to light and freeze-thaw cycles. Reactions were per-
formed in a microseal 96 microplates covered with
optically clear caps (MJ Research, Waltham, MA) and
placed in a Opticon 2 thermal cycler. Settings were: 95°C
for 10 min, followed by 40 cycles of 95°C for 10 sec, 64°C
for 20 sec, 72°C for 30 sec, and 84°C for 1 sec for fluores-
cence measurement. After a final extension at 72°C for 10
min, a melting curve was ascertained using the program:
70°C to 95°C, 0.2°C/read, 1 sec hold to confirm product
specificity.
The primers used targeted a 177 bp region of the DENV-2
NS5 gene and quantified (+) strand DENV-2 RNA in the
sample. Standard curves were generated on each plate by
analyzing 2 × 102 to 2 × 108 copies/reaction of DENV-2
from plasmid standards.
Kinetics of DENV-2 replication in orally infected mosquitoesF gure 8
Kinetics of DENV-2 replication in orally infected 
mosquitoes. DENV-2 titers in individual Chetumal mosqui-
toes were determined by plaque assay at 3, 4, 7, 10, 14, 18 
and 21 dpi. Each box in the graph represents mean and range 
values of viral titers (n = 10) in mosquitoes for each time 
point.Page 11 of 13
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